These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32848393)

  • 21. Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis.
    Hu Y; Zhang K; Zhu X; Zheng X; Wang C; Niu X; Jiang T; Ji X; Zhao W; Pang L; Qi Y; Li F; Li L; Xu Z; Gu W; Zou H
    Int J Nanomedicine; 2021; 16():2173-2186. PubMed ID: 33758505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
    Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
    Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual drug-loaded nano-platform for targeted cancer therapy: toward clinical therapeutic efficacy of multifunctionality.
    Ma Z; Li N; Zhang B; Hui Y; Zhang Y; Lu P; Pi J; Liu Z
    J Nanobiotechnology; 2020 Sep; 18(1):123. PubMed ID: 32887626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel-loaded polymeric nanoparticles combined with chronomodulated chemotherapy on lung cancer: In vitro and in vivo evaluation.
    Hu J; Fu S; Peng Q; Han Y; Xie J; Zan N; Chen Y; Fan J
    Int J Pharm; 2017 Jan; 516(1-2):313-322. PubMed ID: 27884713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment.
    Song Y; Cai H; Yin T; Huo M; Ma P; Zhou J; Lai W
    Int J Nanomedicine; 2018; 13():1585-1600. PubMed ID: 29588586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells.
    Xu Y; Shen M; Li Y; Sun Y; Teng Y; Wang Y; Duan Y
    Oncotarget; 2016 Apr; 7(15):20890-901. PubMed ID: 26956046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic chemotherapy with paclitaxel nanoparticles induced apoptosis in lung cancer in vitro and in vivo.
    Zhao X; Fan J; Wu P; Wei C; Chen Q; Ming Z; Yan J; Yang L
    Int J Nanomedicine; 2019; 14():1299-1309. PubMed ID: 30863062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paclitaxel nanosuspension coated with P-gp inhibitory surfactants: II. Ability to reverse the drug-resistance of H460 human lung cancer cells.
    Gao L; Liu G; Ma J; Wang X; Wang F; Wang H; Sun J
    Colloids Surf B Biointerfaces; 2014 May; 117():122-7. PubMed ID: 24632038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A convenient protonated strategy for constructing nanodrugs from hydrophobic drug-inhibitor conjugates to reverse tumor multidrug resistance.
    Wang P; Wang Y; Xia X; Wu J; Lin J; Huang W; Yan D
    Nanoscale; 2024 May; 16(17):8434-8446. PubMed ID: 38592819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic Antitumor Effects on Drug-Resistant Breast Cancer of Paclitaxel/Lapatinib Composite Nanocrystals.
    Wang J; Lv FM; Wang DL; Du JL; Guo HY; Chen HN; Zhao SJ; Liu ZP; Liu Y
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32019194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors.
    Wang C; Guan W; Peng J; Chen Y; Xu G; Dou H
    Acta Biomater; 2020 Feb; 103():247-258. PubMed ID: 31846802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-delivery of paclitaxel and gemcitabine by methoxy poly(ethylene glycol)-poly(lactide-coglycolide)-polypeptide nanoparticles for effective breast cancer therapy.
    Dong S; Guo Y; Duan Y; Li Z; Wang C; Niu L; Wang N; Ma M; Shi Y; Zhang M
    Anticancer Drugs; 2018 Aug; 29(7):637-645. PubMed ID: 29846247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient antitumor effect of co-drug-loaded nanoparticles with gelatin hydrogel by local implantation.
    Zhang H; Tian Y; Zhu Z; Xu H; Li X; Zheng D; Sun W
    Sci Rep; 2016 May; 6():26546. PubMed ID: 27226240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study.
    Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M
    Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pH and redox dual-responsive copolymer micelles with surface charge reversal for co-delivery of all-
    Zhang Y; Peng L; Chu J; Zhang M; Sun L; Zhong B; Wu Q
    Int J Nanomedicine; 2018; 13():6499-6515. PubMed ID: 30410335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
    Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
    Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-Delivery of Curcumin and Paclitaxel by "Core-Shell" Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer.
    Zhao MD; Li JQ; Chen FY; Dong W; Wen LJ; Fei WD; Zhang X; Yang PL; Zhang XM; Zheng CH
    Int J Nanomedicine; 2019; 14():9453-9467. PubMed ID: 31819443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
    Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells.
    Zhang J; Wang L; Fai Chan H; Xie W; Chen S; He C; Wang Y; Chen M
    Sci Rep; 2017 May; 7():46057. PubMed ID: 28470171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.